Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
RATIONALE: The basal ganglia play an important role in motor control, which is dependent on dopaminergic input. Preparation of a motor response has been associated with dopamine release in the basal ganglia, and response readiness may therefore serve as a pharmacodynamic marker of dopamine activity. METHODS: We measured response readiness using the amplitude of the contingent negative variation (CNV), a slow negative shift in the electroencephalogram. The CNV is evoked in a paradigm in which a warning stimulus (S1) signals the occurrence of the imperative stimulus (S2) 4 s later, to which the participant has to respond. CNV was assessed in healthy volunteers after administration of placebo or 10, 20 or 40 mg of methylphenidate, a catecholamine re-uptake blocker which primarily enhances the synaptic concentration of dopamine and to a lesser extent also noradrenaline. In addition, participants filled out two visual analogue scales measuring subjective ratings of mood and alertness: Profile of Mood States and Bond and Lader. RESULTS: Methylphenidate dose dependently increased CNV amplitude and decreased reaction times. Furthermore, participants reported improved mood, feeling more alert, vigorous and content and less angry and tired after methylphenidate. CONCLUSIONS: These results indicate that dopamine availability increases response readiness as measured by the CNV paradigm. The CNV appears to be a good candidate biomarker for assessing changes in dopaminergic function by treatments that either directly or indirectly target the dopaminergic system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Dopamine and the regulation of cognition and attention
Nieoullon, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00011-4 · Cited by 1,131 · cited 1×
“Dopamine abnormalities are implicated in neuropsychiatric diseases such as Parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder (ADHD; Iversen and Iversen 2007; Nieoullon 2002), but the precise nature of these disturbances and their treatments remains to be understood.”
BackgroundContingent negative variation (CNV) and psychological processes in man
Tecce, J. J. (1972) · Psychological Bulletin · doi:10.1037/h0032177 · Cited by 671 · cited 1×
“The occurrence of this wave has been associated with expectation, anticipation, orientation, attention, intention to act, motivation and response readiness (Bares et al. 2003; Tecce 1972; van Boxtel and Brunia 1994; Walter et al. 1964).”
BackgroundBrain activity relating to the contingent negative variation: An fMRI investigation
Nagai, Y., Critchley, H. D., Featherstone, E., Fenwick, P. B. C., Trimble, M. R., & Dolan, R. J. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.10.036 · Cited by 377 · cited 1×
“However, previous research suggests that the CNV is generated in the basal ganglia (Fan et al. 2007; Nagai et al. 2004).”
BackgroundArnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363
Volkow, N. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00104-9 · Cited by 217 · cited 1×
“Based on the literature, it was expected that methylphenidate levels in the blood would peak 2 h after drug intake (Spencer et al. 2006; Volkow et al. 2002).”
BackgroundNagai, T., Takuma, K., Kamei, H., Ito, Y., Nakamichi, N., Ibi, D., Nakanishi, Y., Murai, M., Mizoguchi, H., Nabeshima, T., et al. (2007) · Learning & Memory · doi:10.1101/lm.461407 · Cited by 184
Methylphenidate Decreased the Amount of Glucose Needed by the Brain to Perform a Cognitive Task
Volkow, N. D., Fowler, J. S., Wang, G.-J., Telang, F., Logan, J., Wong, C., Ma, J., Pradhan, K., Benveniste, H., & Swanson, J. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002017 · Cited by 117
Cited by
Beyond the FRN: Broadening the time-course of EEG and ERP components implicated in reward processing
Glazer, J. E., Kelley, N. J., Pornpattananangkul, N., Mittal, V. A., & Nusslock, R. (2018) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2018.02.002 · Cited by 361
Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies
Linssen, A. M. W., Sambeth, A., Vuurman, E. F. P. M., & Riedel, W. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001594 · Cited by 159
“For a more detailed prescription of task procedures and dependent measures see (Linssen et al., 2011).”
BackgroundMethodInfluentialSelf-citationBoecker-Schlier, R., Holz, N. E., Buchmann, A. F., Blomeyer, D., Plichta, M. M., Jennen-Steinmetz, C., Wolf, I., Baumeister, S., Treutlein, J., Rietschel, M., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.006 · Cited by 42
Kishore, K., Ray, K., Anand, J. P., Thakur, L., Kumar, S., & Panjwani, U. (2013) · Brain and Cognition · doi:10.1016/j.bandc.2013.09.005 · Cited by 19
Jarczok, T. A., Haase, R., Bluschke, A., Thiemann, U., & Bender, S. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.05.003 · Cited by 18
Metadata
- Authors
- Linssen, A. M. W., Vuurman, E. F. P. M., Sambeth, A., Nave, S., Spooren, W., Vargas, G., Santarelli, L., & Riedel, W. J.
- Venue
- Psychopharmacology
- Published
- 2011-05-20
- Volume
- 218
- Issue
- 3
- Pages
- 533-542
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2131647451
- Cited by
- 82
- References
- 8
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate. https://app.cochat.ai/papers/10.1007/s00213-011-2345-x
- The paper
- Linssen, A. M. W., Vuurman, E. F. P. M., Sambeth, A., Nave, S., Spooren, W., Vargas, G., Santarelli, L., & Riedel, W. J. (2011). Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate. Psychopharmacology. https://doi.org/10.1007/s00213-011-2345-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.